Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome

NCT00004393 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.

NCT NCT00004393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
Lead sponsor
National Center for Research Resources (NCRR)
Phase
Phase 2
Overall status
Completed
Start date
July 31, 1997
Completion date
September 30, 2000
Enrollment
50
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tourette syndrome